Integrated Wealth Management (Ohio)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$485K Buy
1,854
+2
+0.1% +$513 0.48% 54
2026
Q2
$466K Hold
1,852
– – 0.49% 56
2026
Q1
$403K Buy
1,852
+135
+8% +$29.9K 0.46% 66
2025
Q4
$392K Buy
+1,717
New +$391K 0.44% 62

Other funds holding ABBV

Integrated Wealth Management (Ohio)'s ABBV Position: Q3 2026 in Review

Integrated Wealth Management (Ohio) increased its AbbVie (ABBV) stake by 0.11% in Q3 2026, buying an estimated $513 and bringing the position to 1,854 shares worth $485K. The position accounts for 0.48% of the portfolio, ranked #54.

Integrated Wealth Management (Ohio) first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Integrated Wealth Management (Ohio) held 1,854 shares of AbbVie worth $485K as of Q3 2026.
  • Integrated Wealth Management (Ohio) bought 2 AbbVie shares in Q3 2026, an estimated $513.
  • AbbVie made up 0.48% of Integrated Wealth Management (Ohio)'s portfolio in Q3 2026, its #54 holding.
  • Integrated Wealth Management (Ohio) first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Integrated Wealth Management (Ohio)'s 13F filing for Q3 2026, filed 19 Oct 2026.